Business Development & Strategy

Business Development & Strategy

Search our available technologies

search icon

Investors / Industry

Featured Technology

Pretargeted radioimmunotherapy for the treatment of Multiple Myeloma & B cell malignancies

Anti-CD38 and anti-BCMA bispecific antibodies deliver targeted radioimmunotherapy and avoid systemic toxicity.

See all featured technologies

News / Announcements

What's Happening

Read stories about the accomplishments of our business partners and Fred Hutch scientists.

Find A Representative

Contact Us

We work with Hutch faculty members and research staff, health care executives, investors, biotech leaders, entrepreneurs and public agencies to facilitate commercialization.

Fostering Partnerships

About Us

Managing and commercializing the intellectual property assets of Fred Hutch by seeking partners to revolutionize how we treat cancer.  

Seminars / Events

Join Us

Find events hosted by Fred Hutch's Business Development & Strategy team and our partners.